Table 2 Investigations
ECG parameters | Numerical value | ECG finding | n = 40 |
|---|---|---|---|
Heart Rate(bpm) [Normal range −60 to −100] | 89 (71, 100) | Normal Sinus Rhythm | 24 (60%) |
| Â | Â | Bradycardia | 10 (25%) |
| Â | Â | Tachycardia | 6 (15%) |
QRS duration (ms) [Normal range −80 to −100] | 100 (80, 100) | Prolonged QRS | 14 (35%) |
| Â | Â | Normal QRS | 26(65%) |
| Â | Â | QRS Axis deviation | 6(62.5%) |
QT Duration (ms) [Normal range −400 to −440] | 390 (320, 490) |  |  |
QTc interval (ms) [Normal range −350 to −460] | 481 (437, 530) | Normal QT | 9(22.5%) |
| Â | Â | Prolonged QT | 15(37.5%) |
RR interval(ms) [Normal range −600 to −1200] | 650 (600, 825) |  |  |
ECHO Parameters (n = 40) | n% |
|---|---|
LVEF [N = 55%—75%] | 43 ± 9% |
Abnormal Hypertrophy | 5 (12.5%) |
Right Ventricular Dysfunction | 1 (2.5%) |
Left Ventricular Dysfunction | 18 (45%) |
Valve Abnormalities (Stenosis or Regurgitation) | 17 (42.5%) |
Ischemic Heart Disease | 8 (20%) |
CAG parameters (n = 40) | n % |
|---|---|
Mild stenosis | 10 (25%) |
Subcritical stenosis | 6 (15%) |
Normal CAG | 24 (60%) |
Follow up ECHO (n = 24) | n % |
|---|---|
Resolution of wall motion abnormalities | 18 (75%) |
Improvement in LVEF | 18 (75%) |